{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:20:12Z","timestamp":1760908812285},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ejso.2013.02.006","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T17:50:18Z","timestamp":1363197018000},"page":"786-791","source":"Crossref","is-referenced-by-count":13,"title":["Outcomes and patterns of secondary relapse in platinum-sensitive ovarian cancer: Implications for tertiary cytoreductive surgery"],"prefix":"10.1016","volume":"39","author":[{"given":"J.","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.L.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.J.","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.Y.","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2013.02.006_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<144::AID-CNCR20>3.0.CO;2-X","article-title":"The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma","volume":"88","author":"Eisenkop","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2013.02.006_bib2","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/cncr.20106","article-title":"Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?","volume":"100","author":"Zang","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2013.02.006_bib3","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2013.02.006_bib4","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in recurrent ovarian cancer: the arbeitsgemeinschaft gynaekologische onkologie (AGO) DESKTOP OVAR Trial","volume":"13","author":"Harter","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.02.006_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncr.22447","article-title":"Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome","volume":"109","author":"Salani","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2013.02.006_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/annonc\/mdn591","article-title":"The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer","volume":"20","author":"Oksefjell","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2013.02.006_bib7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jso.21491","article-title":"Surgery in recurrent epithelial ovarian cancer: benefits on survival for patients with residual disease of 0.1\u20131 cm after secondary cytoreduction","volume":"101","author":"Tian","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.02.006_bib8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1245\/s10434-011-1873-2","article-title":"A\u00a0risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection","volume":"19","author":"Tian","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.02.006_bib9","author":"Shanghai Gynecologic Oncology Group"},{"key":"10.1016\/j.ejso.2013.02.006_bib10","author":"Arbeitsgemeinschaft Gynaekologische Onkologie(AGO)"},{"key":"10.1016\/j.ejso.2013.02.006_bib11","author":"National Cancer Institute (NCI)"},{"key":"10.1016\/j.ejso.2013.02.006_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2004.07.033","article-title":"Tertiary cytoreduction in patients with recurrent ovarian carcinoma","volume":"95","author":"Leitao","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.02.006_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ygyno.2006.08.037","article-title":"Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome","volume":"104","author":"Karam","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.02.006_bib14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jso.21146","article-title":"A\u00a0third evaluation of tertiary cytoreduction","volume":"98","author":"Gultekin","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.02.006_bib15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ygyno.2010.01.046","article-title":"Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series","volume":"117","author":"Shih","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.02.006_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1245\/s10434-010-1245-3","article-title":"Clinical outcome of tertiary surgical cytoreduction in patients with recurrent epithelial ovarian cancer","volume":"18","author":"Fotopoulou","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.02.006_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jso.21288","article-title":"Intra-abdominal tumour dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer","volume":"99","author":"Sehouli","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.02.006_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumours","volume":"92","author":"Therasse","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2013.02.006_bib19","doi-asserted-by":"crossref","first-page":"187s","DOI":"10.1200\/JCO.2003.01.223","article-title":"Use of CA-125 to assess response to new agents in ovarian cancer trials","volume":"21","author":"Rustin","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2013.02.006_bib20","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","article-title":"Early versus delayed treatment of relapsed ovarian cancer(MRC OV05-EORTC 55955): a randomised trial","volume":"376","author":"Rustin","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2013.02.006_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","article-title":"Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA125 agreed by the gynecological cancer intergroup (GCIG)","volume":"21","author":"Rustin","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2013.02.006_bib22","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/bjc.2011.328","article-title":"Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort","volume":"105","author":"Zang","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2013.02.006_bib23","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1245\/s10434-007-9565-7","article-title":"Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma","volume":"14","author":"Salani","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.02.006_bib24","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/1097-0142(197710)40:4<1444::AID-CNCR2820400414>3.0.CO;2-I","article-title":"Lymphangiography in patients with ovarian epithelial cancer: an evaluation of 289 consecutive cases","volume":"40","author":"Musumeci","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2013.02.006_bib25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jso.21940","article-title":"Surgical implications of mesenteric lymph node metastasis from advanced ovarian cancer after bowel resection","volume":"104","author":"Baiocchi","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.02.006_bib26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejso.2011.10.006","article-title":"Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer","volume":"38","author":"Gouy","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2013.02.006_bib27","article-title":"Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation","author":"Fotopoulou","year":"2012","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798313002503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798313002503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T21:28:55Z","timestamp":1595539735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798313002503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0748798313002503"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2013.02.006","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}